Roberta Gagliardini

2.6k total citations
65 papers, 544 citations indexed

About

Roberta Gagliardini is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Roberta Gagliardini has authored 65 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 36 papers in Virology and 21 papers in Epidemiology. Recurrent topics in Roberta Gagliardini's work include HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (31 papers) and HIV/AIDS Research and Interventions (21 papers). Roberta Gagliardini is often cited by papers focused on HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (31 papers) and HIV/AIDS Research and Interventions (21 papers). Roberta Gagliardini collaborates with scholars based in Italy, United Kingdom and United States. Roberta Gagliardini's co-authors include Andrea De Luca, Simona Di Giambenedetto, Andrea Antinori, Massimiliano Fabbiani, Alberto Borghetti, Francesca Lombardi, Roberto Cauda, Arturo Ciccullo, Gianmaria Baldin and Alessandra Vergori and has published in prestigious journals such as Clinical Infectious Diseases, International Journal of Molecular Sciences and AIDS.

In The Last Decade

Roberta Gagliardini

59 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta Gagliardini Italy	15	411	281	129	120	67	65	544
Thérèse Staub Luxembourg	15	379 0.9×	251 0.9×	134 1.0×	47 0.4×	61 0.9×	29	576
Birgit Thorup Røge Denmark	13	478 1.2×	359 1.3×	245 1.9×	174 1.4×	98 1.5×	30	682
P. de Truchis France	10	351 0.9×	251 0.9×	201 1.6×	147 1.2×	41 0.6×	20	589
Barbara Bastow United States	12	405 1.0×	359 1.3×	160 1.2×	171 1.4×	17 0.3×	19	602
Brian Gazzard United Kingdom	15	480 1.2×	337 1.2×	223 1.7×	189 1.6×	13 0.2×	37	797
M.A. Valantin France	13	305 0.7×	159 0.6×	216 1.7×	99 0.8×	131 2.0×	27	484
Alessandra Vergori Italy	13	294 0.7×	78 0.3×	95 0.7×	31 0.3×	59 0.9×	53	495
Michael K. Klebert United States	8	449 1.1×	166 0.6×	57 0.4×	65 0.5×	13 0.2×	10	569
Anna Danise Italy	13	382 0.9×	289 1.0×	128 1.0×	104 0.9×	57 0.9×	24	504
Kara W Chew United States	15	193 0.5×	78 0.3×	283 2.2×	111 0.9×	235 3.5×	49	577

Countries citing papers authored by Roberta Gagliardini

Since Specialization

Citations

This map shows the geographic impact of Roberta Gagliardini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Gagliardini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Gagliardini more than expected).

Fields of papers citing papers by Roberta Gagliardini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Gagliardini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Gagliardini. The network helps show where Roberta Gagliardini may publish in the future.

Co-authorship network of co-authors of Roberta Gagliardini

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Gagliardini. A scholar is included among the top collaborators of Roberta Gagliardini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Gagliardini. Roberta Gagliardini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lanini, Simone, Andrea De Vito, Maria Mazzitelli, et al.. (2025). All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort. Open Forum Infectious Diseases. 12(8). ofaf455–ofaf455.

Vergori, Alessandra, Giulia Matusali, Eleonora Cimini, et al.. (2025). Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine. International Journal of Molecular Sciences. 26(8). 3521–3521.

Vergori, Alessandra, Patrizia Lorenzini, Ilaria Mastrorosa, et al.. (2024). Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition. AIDS. 39(3). 270–275. 3 indexed citations

Matusali, Giulia, Alessandra Vergori, Eleonora Cimini, et al.. (2024). Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV. Journal of Medical Virology. 96(4). e29598–e29598. 1 indexed citations

Vergori, Alessandra, Alessandro Cozzi‐Lepri, Alessandro Tavelli, et al.. (2024). SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV. International Journal of Infectious Diseases. 144. 107065–107065.

Caputo, Sergio Lo, Alessandro Tavelli, Roberta Gagliardini, et al.. (2024). Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study. International Journal of Infectious Diseases. 143. 106956–106956. 2 indexed citations

Gagliardini, Roberta, Alessandro Tavelli, Giuseppe Lapadula, et al.. (2024). OC-10 Effectiveness of long-acting art with cabotegravir/rilpivirine in the icona cohort. A8–A9.

Cicalini, Stefania, Simone Lanini, Roberta Gagliardini, et al.. (2024). Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study. Pharmaceuticals. 17(12). 1706–1706. 1 indexed citations

Galli, Laura, Roberta Gagliardini, Filippo Lagi, et al.. (2024). Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ Open. 14(2). e080606–e080606. 6 indexed citations

10.

Armenia, Daniele, Roberta Gagliardini, Claudia Alteri, et al.. (2023). Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals. Journal of Clinical Virology. 168. 105551–105551. 4 indexed citations

11.

Monforte, Antonella d’Arminio, Alessandro Tavelli, Roberto Rossotti, et al.. (2023). Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort. Liver International. 43(10). 2130–2141. 1 indexed citations

12.

Giacomelli, Andrea, Roberta Gagliardini, Alessandro Tavelli, et al.. (2023). Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network. International Journal of Infectious Diseases. 136. 127–135. 10 indexed citations

13.

Gagliardini, Roberta, Patrizia Lorenzini, Alessandro Cozzi‐Lepri, et al.. (2022). Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failures. Journal of Global Antimicrobial Resistance. 32. 158–163. 5 indexed citations

14.

Vergori, Alessandra, Antonio Boschini, Stefania Notari, et al.. (2022). SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak. Viruses. 14(7). 1575–1575. 10 indexed citations

15.

Cingolani, Antonella, Alessandro Tavelli, Franco Maggiolo, et al.. (2022). Awareness and perception of accuracy of the Undetectable=Untransmittable message (U=U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people having unprotected sex. AIDS Care. 35(6). 923–933. 4 indexed citations

16.

Matusali, Giulia, Francesca Colavita, Daniele Lapa, et al.. (2021). SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus. Viruses. 13(4). 655–655. 40 indexed citations

17.

Lombardi, Francesca, Andrea Giacomelli, Daniele Armenia, et al.. (2020). Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database. International Journal of Antimicrobial Agents. 57(2). 106252–106252. 15 indexed citations

18.

Borghetti, Alberto, Gianmaria Baldin, Francesca Lombardi, et al.. (2018). Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication. HIV Medicine. 19(7). 452–454. 37 indexed citations

19.

Ciccullo, Arturo, Roberta Gagliardini, Gianmaria Baldin, et al.. (2018). An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy. HIV Medicine. 19(6). 369–375. 10 indexed citations

20.

Ciccullo, Arturo, A D’Avino, Gianmaria Baldin, et al.. (2018). Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice.. PubMed. 26(4). 336–340. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact